190
Participants
Start Date
June 21, 2011
Primary Completion Date
February 20, 2019
Study Completion Date
February 20, 2019
PF-05082566
Intravenous, Dose escalation, once per month
rituximab
Intravenous, 375 mg/m2, once per week for 4 weeks
PF-05082566
IV, Dose escalation, once per month
Peter MacCallum Cancer Centre, Melbourne
Memorial Sloan Kettering Cancer Center, New York
Georgetown University Medical Center Department of Pharmacy, Research, Washington D.C.
MedStar Georgetown University Hospital, Washington D.C.
Ospedale San Raffaele di Milano, Milan
Emory University Hospital Midtown, Atlanta
Emory University Hospital, Atlanta
The Emory Clinic, Building A, Atlanta
The Emory Clinic, Atlanta
Winship Cancer Institute, Atlanta
Centre d'investigation clinique, Rennes
Az. Ospedaliera-Univer. di Bologna Policlinico S. Orsola Malpighi, Bologna
University of Michigan Health System, Ann Arbor
Barnes-Jewish Hospital, St Louis
Washington University Infusion Center Pharmacy, St Louis
Washington University School of Medicine, St Louis
Siteman Cancer Center- South County, St Louis
Siteman Cancer Center-West County, Creve Coeur
Siteman Cancer Center - St. Peters, City of Saint Peters
The University of Texas - M.D. Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics, LLC, San Antonio
Research Administration Office: Clinical Research Unit, Los Angeles
Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles
UCLA Bowyer Clinic, Los Angeles
UCLA Hematology-Oncology Clinic, Los Angeles
Santa Monica UCLA Hematology & Oncology Clinic, Santa Monica
City of Hope, Duarte
UC San Diego Medical Center-La Jolla (Jacobs Medical Center/Thornton Hospital), La Jolla
UC San Diego Moores Cancer Center, La Jolla
UC San Diego Medical Center - Hillcrest, San Diego
Stanford University Medical Center, Palo Alto
Stanford University Medical Center, Palo Alto
Stanford University Medical Center, Stanford
Seattle Cancer Care Alliance, Seattle
University of Washington Medical Center, Seattle
UC San Diego Moores Cancer Center-Investigational Drug Services, La Jolla
Brigham and Woman's Hospital, Boston
Dana-Farber Cancer Institute, Boston
Barnes-Jewish Hospital, St Louis
National Cancer Center Hospital East, Kashiwa
Akita University Hospital, Akita
The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo
Lead Sponsor
Pfizer
INDUSTRY